900 results on '"Kojima, Kensuke"'
Search Results
2. Novel paired CD13-negative (MT-50.1) and CD13-positive (MT-50.4) HTLV-1-infected T-cell lines with differential regulatory T cell-like activity
3. Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
4. Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma
5. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
6. The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
7. Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease
8. Targeting cis-regulatory elements of FOXO family is a novel therapeutic strategy for induction of leukemia cell differentiation
9. Cyclin D2-positive mantle cell lymphoma with t(2;12)(p12;p13) arising in immune deficiency/dysregulation
10. Algorithms and Hardness Results for the Maximum Balanced Connected Subgraph Problem
11. Dynamic changes in postoperative risk of recurrence of non-small cell lung cancer according to variations in PD-L1 expression levels
12. BDDs Naturally Represent Boolean Functions, and ZDDs Naturally Represent Sets of Sets
13. Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics
14. PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study
15. Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease
16. Sharper and Simpler Nonlinear Interpolants for Program Verification
17. A Novel Four-way Translocation Variant t(8;14;15;21)(q22;q22;q15;q22.1) in Acute Myeloid leukemia with RUNX1: : RUNX1T1
18. Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML
19. Generalized Homogeneous Polynomials for Efficient Template-Based Nonlinear Invariant Synthesis
20. Influence of Valence Band Offset at the Hole Transport Material/CH3NH3PbI3 Interface on Device Performance Using Fluorinated Spiro-OMeTAD.
21. Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
22. Unilateral lymphadenitis caused by community-associated methicillin-resistant Staphylococcus aureus ST834 strain
23. Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias
24. Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
25. PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
26. Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis
27. Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor
28. Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation
29. Clinical impact of the CONUT score in patients with multiple myeloma
30. Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia
31. A Nonstandard Functional Programming Language
32. Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)
33. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma
34. Automated Verification of Functional Correctness of Race-Free GPU Programs
35. Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg
36. FZR1 loss increases sensitivity to DNA damage and consequently promotes murine and human B-cell acute leukemia
37. Primary pulmonary diffuse large B cell lymphoma presenting as bulky bilateral lung tumors
38. Algorithms and Hardness Results for the Maximum Balanced Connected Subgraph Problem
39. Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy
40. Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis
41. Sensitivity Analyses of Initial Compositions and Cross Sections for Activation Products of In-Core Structure Materials
42. Three coexisting lymphomas in a single patient: composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma
43. Supplemental File 3 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition
44. Supplemental File 1 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition
45. Supplemental File 2 from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition
46. Supplemental Information from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition
47. Supplemental Figures 1 and 2 from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
48. Data from Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition
49. Supplemental Methods from Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
50. Supplementary Figure 1 from The Novel Tryptamine Derivative JNJ-26854165 Induces Wild-Type p53- and E2F1-Mediated Apoptosis in Acute Myeloid and Lymphoid Leukemias
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.